Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026)

Sintx Technologies' (SINT) quarterly Net Income towards Common Stockholders came in at -$2.8 million in Q1 2026, down 22.87% year-on-year from -$3.7 million in Q1 2025, and down 27.36% quarter-over-quarter from -$2.2 million in Q4 2025.

Sintx Technologies (SINT) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends

Sintx Technologies' Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 22.87% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$17.6 million, a 41.64% decrease from a year earlier, with the FY2025 full-year figure at -$17.1 million, down 54.96% from the prior year.
  • Net Income towards Common Stockholders eased to -$2.8 million in Q1 2026 per SINT's latest filing, from -$2.2 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$1.7 million in Q4 2024 and bottomed at -$10.3 million in Q3 2025.
  • The 5-year median for Net Income towards Common Stockholders is -$2.7 million (2022), against an average of -$3.7 million.
  • Across the five-year window, Net Income towards Common Stockholders plunged 294.0% in 2022 and soared 72.4% in 2023, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$8.4 million in 2022, then surged by 72.4% to -$2.3 million in 2023, then increased by 26.97% to -$1.7 million in 2024, then slumped by 30.68% to -$2.2 million in 2025, then decreased by 27.36% to -$2.8 million in 2026.
  • Per Business Quant, the three latest SINT Net Income towards Common Stockholders figures stand at -$2.8 million (Q1 2026), -$2.2 million (Q4 2025), and -$10.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.59 Bn 176.29 Bn 6.27 Bn 1.08 Bn
2 Stryker 129.07 Bn 126.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.58 Bn 99.36 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.64 Bn 67.19 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.38 Bn 44.71 Bn 1.29 Bn -
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.13 Bn 25.84 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.90 Bn 26.33 Bn - -
9 Koninklijke Philips 24.27 Bn 21.15 Bn 2.07 Bn 176.78 Mn
10 Sintx Technologies 5.70 Mn 3.81 Mn 144,000.00 -2.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.82 Mn
Dec 31, 2025 -2.22 Mn
Sep 30, 2025 -10.26 Mn
Jun 30, 2025 -2.32 Mn
Mar 31, 2025 -2.30 Mn
Dec 31, 2024 -1.70 Mn
Sep 30, 2024 -6.24 Mn
Jun 30, 2024 -2.20 Mn
Mar 31, 2024 -3.73 Mn
Dec 31, 2023 -2.32 Mn
Sep 30, 2023 -3.19 Mn
Jun 30, 2023 -2.48 Mn
Mar 31, 2023 -4.44 Mn
Dec 31, 2022 -8.41 Mn
Sep 30, 2022 -2.72 Mn
Jun 30, 2022 -2.51 Mn
Mar 31, 2022 -2.85 Mn
Dec 31, 2021 -2.13 Mn
Sep 30, 2021 -2.34 Mn
Jun 30, 2021 -2.20 Mn